Learn More
Medchemexpress LLC CDK/HDAC-IN-3 | 2944087-54-9 | 99.60% | 509.34 | 50 MG

Supplier: Medchemexpress LLC HY14981950MG
CDK/HDAC-IN-3 is an orally active HDACs/CDKs dual inhibitor. It potently and selectively inhibits CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3. This compound can be used for acute myeloid leukemia (AML), significantly inducing differentiation of leukemic stem-like cells and inhibiting AML proliferation. It also demonstrates inhibitory effects on U937, HL-60, SKNO-1, and Kaumi-1 cells.
- Potent and selective dual inhibition of HDACs/CDKs.
- Inhibits CDK9, CDK12, CDK13, HDAC1, HDAC2, HDAC3.
- Induces differentiation of leukemic stem-like cells.
- Inhibits AML proliferation.
- Effective against U937, HL-60, SKNO-1, and Kaumi-1 cells.
- Demonstrates adequate oral bioavailability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.